期刊文献+

^(18)F-FDG PET/CT显像与^(99m)Tc-MDP全身骨显像诊断骨转移的价值 被引量:4

Comparison of ^(18)F-FDG PET/CT and ^(99m)Tc-MDP whole body bone scan in detection of bone metastases
下载PDF
导出
摘要 目的评价18F-脱氧葡萄糖(FDG)PET/CT与99mTc-亚甲基二膦酸盐(MDP)ECT全身骨显像对骨转移肿瘤的诊断价值。方法对29例经病理或临床证实的恶性肿瘤患者进行18F-FDGPET/CT显像与99mTc-MDPECT全身骨显像,并评价显像效果。结果26例肿瘤患者18F-FDGPET/CT显像为阳性,其中有17例患者发现骨转移45处;在99mTc-MDPECT全身骨显像中,有20例患者发现骨转移77处。结论18F-FDGPET/CT显像对恶性肿瘤具有较高的诊断价值,而99mTc-MDPECT全身骨显像是诊断骨转移的常规方法。 Objective To evaluate the diagnostic value of ^18 F-FDG PET/CT and ^99mTc-MDP ECT in detection of bone metastases. Methods ^18F-FDG PET/CT and ^99mTc-MDP ECT whole body bone scan were performed in 29 patients with various tumors. Results The results of ^18F-FDG PET/CT were positive in 26 patients, 17 cases with bone metastases were detected. In the patients who performed ^99mTc-MDP ECT,20 cases with bone metastasses were found. Conclusion ^99mTc-MDP ECT whole body bone scan has been usually used as the imaging modality of choice in the diagnosis of bone metastases, while ^18 F-FDG PET/CT is a valuable method in the diagnosis of malignant tumors.
出处 《重庆医学》 CAS CSCD 2005年第8期1131-1132,共2页 Chongqing medicine
关键词 ^18F-FDG PET/CT ^99MTC-MDP ECT 骨转移 全身骨显像 ^18 F-FDG PET/CT ^99mTc-MDP ECT bone metastasis whole body bone scan
  • 相关文献

参考文献2

二级参考文献13

  • 1赵军,孙启银,李家敏,王明芳,孙爱君,徐顾海,石杏芬.^(18)F-FDG PET全身显像诊断乳腺癌及其转移灶的价值[J].临床医学影像杂志,1996,7(4):243-245. 被引量:1
  • 2赵军 孙启银 等.-[J].临床医学影像杂志,1996,7(4):243-245.
  • 3赵军 颜廷秀 等.-[J].中华核医学杂志,1996,16(1):51-51.
  • 4程午樱 见:丁虹 赵军 管一晖 主编.G-CSF影响骨髓^18F-FDG摄取一例[A].见:丁虹,赵军,管一晖,主编.PET临床病例精选[C].香港:雅艺出版设计公司,2002.176.178.
  • 5Hsia TC, Shen YY, Yen RF, et al. Comparing whole body ^18F-2-deoxyglucose positron emission tomography and ^99Tc^m-methylene diphosphate bone scan to detect bone metastases in patients with non-small cell lung cancer. Neoplasma, 2002, 49: 267-271.
  • 6Ohta M, Tokuda Y, Suzuki Y, et al. Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with ^99Tc^m-MDP bone scintigraphy. Nucl Med Commun, 2001, 22: 875-879.
  • 7Yang SN, Liang JA, Lin FJ, et al. Comparing whole body ^18F-2-deoxyglucose positron emission tomography and ^99Tc^m-methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer. J Cancer Res Clin Oncol, 2002, 128: 325-328.
  • 8Chung JK, Kim YK, Yoon JK, et al. Diagnostic usefulness of ^18F-FDG whole body PET in detection of bony metastases compared to ^99Tc^m-MDP bone scan. J Nucl Med, 1999, 40: 96P.
  • 9Shreve PD, Grossman HB, Gross MD, et al. Metastatic prostate cancer:initial findings of PET with 2-deoxy-2-^18F-fluoro-D-glucose. Radiology,1996, 199: 751-756.
  • 10Cook GJ, Houston S, Rubens R, et al. Detection of bone metastases in breast cancer by ^18F-FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol, 1998, 16: 3375-3379.

共引文献21

同被引文献55

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部